144 related articles for article (PubMed ID: 34002462)
1. miRNA-10a-5p inhibits cell metastasis in hepatocellular carcinoma via targeting SKA1.
Shen D; Zhao HY; Gu AD; Wu YW; Weng YH; Li SJ; Song JY; Gu XF; Qiu J; Zhao W
Kaohsiung J Med Sci; 2021 Sep; 37(9):784-794. PubMed ID: 34002462
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA
Gong X; Zhu Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
[No Abstract] [Full Text] [Related]
4. Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.
Arai T; Okato A; Kojima S; Idichi T; Koshizuka K; Kurozumi A; Kato M; Yamazaki K; Ishida Y; Naya Y; Ichikawa T; Seki N
Cancer Sci; 2017 Oct; 108(10):2088-2101. PubMed ID: 28746769
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase non-receptor type 12 (PTPN12), negatively regulated by miR-106a-5p, suppresses the progression of hepatocellular carcinoma.
Liang Z; Li X; Duan F; Song L; Wang Z; Li X; Yang P; Li L
Hum Cell; 2022 Jan; 35(1):299-309. PubMed ID: 34784010
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
7. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling.
Shi DM; Li LX; Bian XY; Shi XJ; Lu LL; Zhou HX; Pan TJ; Zhou J; Fan J; Wu WZ
J Exp Clin Cancer Res; 2018 Nov; 37(1):294. PubMed ID: 30486894
[TBL] [Abstract][Full Text] [Related]
8. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
[TBL] [Abstract][Full Text] [Related]
10. MiR-503-5p regulates cell epithelial-to-mesenchymal transition, metastasis and prognosis of hepatocellular carcinoma through inhibiting WEE1.
Jiang SP; Li ZR
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2028-2037. PubMed ID: 30915746
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.
Zhu X; Jiang S; Wu Z; Liu T; Zhang W; Wu L; Xu L; Shao M
Bioengineered; 2021 Dec; 12(1):578-588. PubMed ID: 33517826
[TBL] [Abstract][Full Text] [Related]
12. miR-29a-5p regulates the malignant biological process of liver cancer cells through ARID2 regulation of EMT.
Li W; Jiang Y; Pan Q; Yang G
Adv Clin Exp Med; 2023 May; 32(5):575-582. PubMed ID: 36530029
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1.
Xu Q; Zhu Q; Zhou Z; Wang Y; Liu X; Yin G; Tong X; Tu K
Biomed Pharmacother; 2018 Jul; 103():645-652. PubMed ID: 29679906
[TBL] [Abstract][Full Text] [Related]
14. microRNA-4270-5p inhibits cancer cell proliferation and metastasis in hepatocellular carcinoma by targeting SATB2.
Wang Y; Li CF; Sun LB; Li YC
Hum Cell; 2020 Oct; 33(4):1155-1164. PubMed ID: 32504285
[TBL] [Abstract][Full Text] [Related]
15. Exosomal miR-374c-5p derived from mesenchymal stem cells suppresses epithelial-mesenchymal transition of hepatocellular carcinoma via the LIMK1-Wnt/β-catenin axis.
Ding B; Lou W; Fan W; Pan J
Environ Toxicol; 2023 May; 38(5):1038-1052. PubMed ID: 36722453
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-361-5p Inhibits Tumorigenesis and the EMT of HCC by Targeting Twist1.
Yin LC; Xiao G; Zhou R; Huang XP; Li NL; Tan CL; Xie FJ; Weng J; Liu LX
Biomed Res Int; 2020; 2020():8891876. PubMed ID: 33381597
[TBL] [Abstract][Full Text] [Related]
17. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
Li Y; Chen G; Yan Y; Fan Q
Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
20. Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.
Sun X; Liu Y; Li M; Wang M; Wang Y
Biomed Pharmacother; 2015 May; 72():58-65. PubMed ID: 26054676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
